CYAN - CYANOTECH CORP

0.47
0.470   100.000%

Share volume: 0
Last Updated: 02-16-2024
Pharmaceutical Products/Medicinal Chemicals: -0.12%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
54%
Profitability 50%
Dept financing 50%
Liquidity 7%
Performance 70%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
176.46%
Key data
Stock price
$0.47
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
-$0.29
52 WEEK RANGE
N/A - N/A
52 WEEK CHANGE
N/A
MARKET CAP 
2.200 M
YIELD 
N/A
SHARES OUTSTANDING 
7.392 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Matthew Custer
Region: US
Website: cyanotech.com
Employees: 100
IPO year: 1993
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, and Hawaiian Spirulina Pacifica. The company sells its products as packaged consumer products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors.

Recent news